Cureline is a global precision and translational medicine CRO providing biobanking and human biospecimens (HBS) services to the biopharmaceutical industry since 2003. We cover regulatory affairs and clinical network management in 18 countries from our central biorepository in California (USA). We support therapeutic and diagnostic clinical trials, implement complex research protocols, provide molecular and cellular analyses and deliver translational histology and pathology services. Cureline is a global leader in commercial biobanking with over 600 clients and 3,500+ projects completed. Our expertise includes HBS validation studies, drug R&D, biomarker and CDx development in oncology, AID/inflammation, infectious diseases, metabolic and cardiovascular conditions, maternal health, etc. Our laboratory services are focused on tissue research (histology, IHC, FISH, digital pathology), molecular and cellular assays (DTC, NGS, drug testing) and glycoproteomics. Our Quality Management system is based on the CAP guidelines for research biobanks. For the past eight years Cureline have participated in the human cancer genome (TCGA) and proteome (CPTAC) programs conducted by the National Cancer Institute (NIH, USA) with multiple publications in top peer-reviewed journals (Nature, Cell, NEJM, etc.). Our HBS tissue bank and translational histopathology laboratory are in Brisbane, CA; molecular services laboratory is in San Diego, CA; and we collaborate with major laboratories on cutting-edge technologies for HBS analysis worldwide. You can find more information on www.Cureline.com.
There are two parts to the Festival of Biologics: four conferences covering Antibodies, Immunotherapy, Biosimilars and Clinical Trials and an exhibition featuring solutions for pharma and biotech.
There is a registration fee to attend the conferences. To visit the exhibition is free.